Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm
NCT06582888
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder (VR)
Sponsor: National Institute on Drug Abuse (NIDA)
Conditions
Craving Nicotine Addiction
Interventions
Placebo Varenicline Tartrate
Updated 2 times since 2024 Last updated: Nov 19, 2024 Started: Nov 19, 2024 Primary completion: Aug 15, 2028 Completion: Aug 15, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This EARLY_PHASE1 trial investigates Craving and Nicotine Addiction and is currently actively recruiting participants. National Institute on Drug Abuse (NIDA) leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
2 versions recorded-
Dec 2024 — Present [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Dec 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- National Institute on Drug Abuse (NIDA)
- University of California, San Diego
Data source: University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .